$AMGN News

Amgen contends with data breach, exposing patient information

Kaléo Announces License Agreement with Amgen for Auto-Injector Technology

Amgen (AMGN) To Report Earnings Tomorrow: Here Is What To Expect

Amgen Q2 Earnings Preview: Will the Beat Streak Continue?

Amgen Identifies Unauthorized Activity In Third-party Cloud Environments In July 2026; Reports No Impact To Products, Operations, Or Financial Reporting From Incident; Reports Exfiltration Of Proprietary And Patient Data From Cloud Environments

FIRST AMGEN SCHOLARS PROGRAM IN INDIA LAUNCHES AT IIIT HYDERABAD

AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND

What Analyst Projections for Key Metrics Reveal About Amgen (AMGN) Q2 Earnings

Are Wall Street Analysts Bullish on Amgen Stock?

Amgen (AMGN) Stock Still Looks Below Fair Value Today

Amgen (AMGN) Wins Backing In Europe For Broader Repatha Use

Amgen (AMGN) Stock Moves -1.44%: What You Should Know

Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $360

AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS

Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen Disagrees With FDA Proposal To Withdraw TAVNEOS From U.S. Market; Submitted Data And Analyses To FDA To Request Hearing On TAVNEOS

Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Amgen Inc (NASDAQ:AMGN) Shows Technical Strength and Breakout Setup